These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16798286)

  • 1. Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome.
    de Zegher F; Ibáñez L
    Fertil Steril; 2006 Jul; 86 Suppl 1():S4-5. PubMed ID: 16798286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L; de Zegher F
    Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early metformin therapy to delay menarche and augment height in girls with precocious pubarche.
    Ibáñez L; Lopez-Bermejo A; Diaz M; Marcos MV; de Zegher F
    Fertil Steril; 2011 Feb; 95(2):727-30. PubMed ID: 20883985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
    Ibáñez L; de Zegher F
    Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
    Ibáñez L; Ferrer A; Ong K; Amin R; Dunger D; de Zegher F
    J Pediatr; 2004 Jan; 144(1):23-9. PubMed ID: 14722514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
    Ibáñez L; De Zegher F
    Hum Reprod; 2004 Aug; 19(8):1725-7. PubMed ID: 15229206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.
    Glueck CJ; Goldenberg N; Pranikoff J; Loftspring M; Sieve L; Wang P
    Hum Reprod; 2004 Jun; 19(6):1323-30. PubMed ID: 15117896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.
    Glueck CJ; Golnik KC; Aregawi D; Goldenberg N; Sieve L; Wang P
    Transl Res; 2006 Nov; 148(5):215-22. PubMed ID: 17145568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puberty and polycystic ovary syndrome.
    Witchel SF
    Mol Cell Endocrinol; 2006 Jul; 254-255():146-53. PubMed ID: 16750596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of PCOS in adolescence.
    Warren-Ulanch J; Arslanian S
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):311-30. PubMed ID: 16772160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome.
    Glueck CJ; Salehi M; Sieve L; Wang P
    J Pediatr; 2006 May; 148(5):628-632. PubMed ID: 16737874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS
    Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.
    Ibáñez L; Valls C; Marcos MV; Ong K; Dunger DB; De Zegher F
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4331-7. PubMed ID: 15356029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advance in treatment of polycystic ovary syndrome].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 Dec; 19(114):848-54. PubMed ID: 16521439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
    Luque-Ramírez M; Alvarez-Blasco F; Botella-Carretero JI; Sanchón R; San Millán JL; Escobar-Morreale HF
    Diabetes Care; 2007 Sep; 30(9):2309-13. PubMed ID: 17536071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?
    Nawaz FH; Khalid R; Naru T; Rizvi J
    J Obstet Gynaecol Res; 2008 Oct; 34(5):832-7. PubMed ID: 18834342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polycystic ovary syndrome (PCOS)].
    Thaler CJ
    MMW Fortschr Med; 2007 May; 149(21):33-5. PubMed ID: 17668731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.